NCT00926341View on ClinicalTrials.gov

The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

September 30, 2008

Conditions
Metabolic Syndrome
Interventions
DRUG

Pioglitazone

Tab. Pioglitazone-30 mg/day, oral, 24 weeks

DRUG

Telmisartan

Tab. Telmisartan- 40 mg/day, oral, 24 weeks

Trial Locations (1)

202002

Department of Medicine, J.N.Medical,College, AMU,Aligarh, Aligarh

All Listed Sponsors
lead

Aligarh Muslim University

OTHER

NCT00926341 - The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome | Biotech Hunter | Biotech Hunter